The following is a summary of “Artificial Intelligence-Based Early Prediction of Acute Respiratory Failure in the Emergency ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

COVID-19, the flu, and RSV among the diseases that have seen a rise in cases in the past few weeks. Trump's buyout offer for ...

The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly ...

Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 trial of its lead drug for idiopathic pulmonary fibrosis (IPF) after seeing a ...